{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:14:08Z","timestamp":1761844448562},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lipidjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.jacl.2015.02.005","type":"journal-article","created":{"date-parts":[[2015,3,5]],"date-time":"2015-03-05T04:06:00Z","timestamp":1425528360000},"page":"390-395","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Case report: A novel apolipoprotein A-I missense mutation apoA-I (Arg149Ser)Boston associated with decreased lecithin-cholesterol acyltransferase activation and cellular cholesterol efflux"],"prefix":"10.1016","volume":"9","author":[{"given":"Pimjai","family":"Anthanont","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bela F.","family":"Asztalos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliana","family":"Polisecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benoy","family":"Zachariah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernst J.","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2015.02.005_bib1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/MOL.0b013e32833c1ef6","article-title":"Marked HDL deficiency and\u00a0premature coronary heart disease","volume":"21","author":"Schaefer","year":"2010","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacl.2015.02.005_bib2","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0022-2275(20)32028-9","article-title":"Apolipoprotein A-I: structure-function relationships","volume":"41","author":"Frank","year":"2000","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2015.02.005_bib3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jacl.2012.10.011","article-title":"HDL deficiency due to a new insertion mutation (ApoA-INashua) and review of the literature","volume":"7","author":"Lee","year":"2013","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.jacl.2015.02.005_bib4","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.atherosclerosis.2014.05.935","article-title":"A novel ApoA-I truncation (ApoA-IMytilene) associated with decreased ApoA-I production","volume":"235","author":"Anthanont","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2015.02.005_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1050-1738(01)00163-3","article-title":"The effects of altered apolipoprotein A-I structure on plasma HDL concentration","volume":"12","author":"Sorci-Thomas","year":"2002","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.jacl.2015.02.005_bib6","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1172\/JCI114355","article-title":"Apolipoprotein A-I variants. Naturally occurring substitutions of proline residues affect plasma concentration of apolipoprotein A-I","volume":"84","author":"von Eckardstein","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2015.02.005_bib7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0022-2275(20)37281-3","article-title":"Heterozygosity for apolipoprotein A-I(R160L) Oslo is associated with low levels of high density lipoprotein cholesterol and HDL-subclass LpA-I\/A-II but normal levels of HDL-subclass LpA-I","volume":"38","author":"Leren","year":"1997","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2015.02.005_bib8","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0022-2275(20)32453-6","article-title":"Multiple dysfunctions of two apolipoprotein A-I variants, apoA-I(R160L)Oslo and apoA-I (P165R), that are associated with hypoalphalipoproteinemia in heterozygous carriers","volume":"40","author":"Daum","year":"1999","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2015.02.005_bib9","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0022-2275(20)37205-9","article-title":"A natural apolipoprotein A-I variant, apoA-I (L141R)Pisa, interferes with the formation of alpha-high density lipoproteins (HDL), but not with the formation of pre beta 1-HDL and influences efflux of cholesterol into plasma","volume":"38","author":"Miccoli","year":"1997","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2015.02.005_bib10","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1161\/01.CIR.94.7.1622","article-title":"Compound heterozygosity for a structural apolipoprotein A-I variant, apo A-I (L141R) Pisa, and an apolipoprotein A-I null allele in patients with absence of HDL cholesterol, corneal opacifications, and coronary heart disease","volume":"94","author":"Miccoli","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2015.02.005_bib11","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1161\/01.ATV.0000146325.93749.a8","article-title":"High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants in the Framingham Offspring Study","volume":"24","author":"Asztalos","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2015.02.005_bib12","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jacl.2011.07.002","article-title":"Homozygous lecithin:cholesterol acyltransferase (LCAT) deficiency due to a new loss of function mutation and review of the literature","volume":"5","author":"Roshan","year":"2011","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2015.02.005_bib13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jacl.2013.11.005","article-title":"A kindred with fish eye disease, corneal opacities, marked high-density lipoprotein deficiency, and statin therapy","volume":"8","author":"Dimick","year":"2014","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2015.02.005_bib14","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1194\/jlr.M600403-JLR200","article-title":"Role of LCAT in HDL remodeling: investigation of LCAT deficiency states","volume":"48","author":"Asztalos","year":"2007","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2015.02.005_bib15","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1194\/jlr.M300198-JLR200","article-title":"Apolipoprotein composition of HDL in cholesteryl ester transfer protein deficiency","volume":"45","author":"Asztalos","year":"2004","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2015.02.005_bib16","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1194\/jlr.P900015-JLR200","article-title":"Effects of weight loss, induced by gastric bypass, on HDL remodeling in obese women","volume":"51","author":"Asztalos","year":"2010","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jacl.2015.02.005_bib17","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1161\/ATVBAHA.109.199158","article-title":"The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages","volume":"30","author":"de la Llera-Moya","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2015.02.005_bib18","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1194\/jlr.M500187-JLR200","article-title":"Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux","volume":"46","author":"Asztalos","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2015.02.005_bib19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0022-2275(20)32333-6","article-title":"Three arginine residues in apolipoprotein A-I are critical for activation of lecithin:cholesterol acyltransferase","volume":"42","author":"Roosbeek","year":"2001","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2015.02.005_bib20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2015.02.005_bib21","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","article-title":"HDL cholesterol efflux capacity and incident cardiovascular events","volume":"371","author":"Rohatgi","year":"2014","journal-title":"N Engl J Med"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287415000616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287415000616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T12:44:29Z","timestamp":1651409069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287415000616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S1933287415000616"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2015.02.005","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Case report: A novel apolipoprotein A-I missense mutation apoA-I (Arg149Ser)Boston associated with decreased lecithin-cholesterol acyltransferase activation and cellular cholesterol efflux","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2015.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 National Lipid Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}